MedGenome, a genomics-driven research and diagnostics company, announced that it has acquired the Illumina Hiseq X Ten platform to fuel its research services capability and capacity.
MedGenome having presence in USA, India and Singapore, offers genomics solutions in cancer immunotherapy and diabetes and works with various commercial and academic researchers globally on genomic research projects.
The company is a market leader for genomic diagnostics in South Asia and a leading provider of genomics research services, globally.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
